Middle East & Africa Platelet Rich Plasma (prp) Market Size & Outlook
Middle East & Africa platelet rich plasma (prp) market, 2018-2030 (US$M)
Related Markets
MEA platelet rich plasma (prp) market highlights
- The MEA platelet rich plasma (prp) market generated a revenue of USD 35.0 million in 2023.
- The market is expected to grow at a CAGR of 16.8% from 2024 to 2030.
- In terms of segment, pure prp was the largest revenue generating type in 2023.
- Leukocyte Rich PRP is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2024 to 2030.
MEA data book summary
| Market revenue in 2023 | USD 35.0 million |
| Market revenue in 2030 | USD 103.7 million |
| Growth rate | 16.8% (CAGR from 2023 to 2030) |
| Largest segment | Pure prp |
| Fastest growing segment | Leukocyte Rich PRP |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Pure PRP, Leukocyte Rich PRP |
| Key market players worldwide | Johnson & Johnson, Arthrex, Terumo Corp, Zimmer Biomet Holdings Inc, Stryker Corp, EmCyte Corporation, Dr. PRP USA, Juventix Regenerative Medical, APEX Biologix, Celling Biosciences |
Other key industry trends
- In terms of revenue, MEA region accounted for 5.4% of the global platelet rich plasma (prp) market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 399.9 million by 2030.
Pure prp was the largest segment with a revenue share of 58.57% in 2023. Horizon Databook has segmented the Middle East & Africa platelet rich plasma (prp) market based on pure prp, leukocyte rich prp covering the revenue growth of each sub-segment from 2018 to 2030.
Over the past few years, clinics and hospitals in the Middle East have shown a growing interest in PRP. Several hospitals and clinics in the Middle East are offering PRP treatments, increasing market revenue generation in the region. In addition, ongoing clinical trials for PRP treatments are anticipated to further boost the market growth.
For instance, in May 2020, a clinical trial was published on Clinicaltrials.org., which was expected to be initiated in November 2020. This clinical trial would be conducted in the UAE and study the potential of PRP therapy in restoring ovarian function. Such ongoing research initiatives are expected to propel the adoption of PRP treatment in the region.
Similarly, various conferences, such as the Middle East Orthopaedics Conference, are expected to increase awareness about PRP therapies for various conditions, such as knee osteoarthritis. These factors are expected to contribute to the market growth in the region.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Platelet Rich Plasma (PRP) Market Scope
Platelet Rich Plasma (PRP) Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
MEA platelet rich plasma (prp) market size, by country, 2018-2030 (US$M)
Middle East & Africa Platelet Rich Plasma (PRP) Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
